Source: Public Filings
ENTITY
JW Therapeutics (2126 HK)
JW Therapeutics (2126 HK)
38
Analysis
Health Care • China
JW (Cayman) Therapeutics Co. Ltd operates as a clinical stage therapy platform company. The Company offers developing, manufacturing and commercializing breakthrough cell-based immunotherapies forhematological cancers and solid tumors. JW (Cayman) Therapeutics provides services in China.
more
x